This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Journal:Molecular Cell:2

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 42: Line 42:
-
*<scene name='79/793845/Cvt/1'>Mutation His254Gly mostly contributes to enlargement of active-site pocket in PTE_27</scene>. <span style="color:lime;background-color:black;font-weight:bold;">Wild type PTE is in green</span>, <font color='magenta'><b>PTE_27 in magenta</b></font>, and <span style="color:yellow;background-color:black;font-weight:bold;">His254 in yellow</span>.
+
*<scene name='79/793845/Cvt/11'>Mutation His254Gly mostly contributes to enlargement of active-site pocket in PTE_27</scene>. <span style="color:lime;background-color:black;font-weight:bold;">Wild type PTE is in green</span>, <font color='magenta'><b>PTE_27 in magenta</b></font>, and <span style="color:yellow;background-color:black;font-weight:bold;">His254 in yellow</span>.
-
*<scene name='79/793845/Cvt/2'>Mutations His254Gly and Leu303Thr mostly contribute to enlargement of active-site pocket in PTE_28</scene>. <span style="color:lime;background-color:black;font-weight:bold;">Wild type PTE is in green</span>, <font color='magenta'><b>PTE_28 in magenta</b></font>, <span style="color:yellow;background-color:black;font-weight:bold;">His254 and Leu303 are in yellow</span>.
+
*<scene name='79/793845/Cvt/12'>Mutations His254Gly and Leu303Thr mostly contribute to enlargement of active-site pocket in PTE_28</scene>. <span style="color:lime;background-color:black;font-weight:bold;">Wild type PTE is in green</span>, <font color='magenta'><b>PTE_28 in magenta</b></font>, <span style="color:yellow;background-color:black;font-weight:bold;">His254 and Leu303 are in yellow</span>.
Next catalytic efficiency was measured in the designs that retained high phosphotriesterase activity with the toxic nerve agents, VX, Russian VX (RVX), Soman (GD). PTE_27 exhibited 66-fold increase in VX hydrolysis efficiency relative to wild-type PTE, and PTE_28 exhibited remarkable gains in efficiency of 1,550 and 3,980-fold respectively, in hydrolyzing RVX and GF. Starting from PTE_27, a second round of design was tested, this time directing FuncLib to rank point mutations of PTE_27. 14 designs were experimentally tested, finding that designs PTE_27.14 and PTE_27.16 exhibited increased activities towards GD (32-fold and 122-fold, respectively), and both designs exhibited a 3,000-fold increase in hydrolyzing GF. These designs for the highly toxic nerve agents RVX, GD, and GF, may be suitable for ​''in vivo'' detoxification.
Next catalytic efficiency was measured in the designs that retained high phosphotriesterase activity with the toxic nerve agents, VX, Russian VX (RVX), Soman (GD). PTE_27 exhibited 66-fold increase in VX hydrolysis efficiency relative to wild-type PTE, and PTE_28 exhibited remarkable gains in efficiency of 1,550 and 3,980-fold respectively, in hydrolyzing RVX and GF. Starting from PTE_27, a second round of design was tested, this time directing FuncLib to rank point mutations of PTE_27. 14 designs were experimentally tested, finding that designs PTE_27.14 and PTE_27.16 exhibited increased activities towards GD (32-fold and 122-fold, respectively), and both designs exhibited a 3,000-fold increase in hydrolyzing GF. These designs for the highly toxic nerve agents RVX, GD, and GF, may be suitable for ​''in vivo'' detoxification.

Revision as of 10:15, 12 August 2018

Phosphotriesterase (PTE)

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Jaime Prilusky

This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
Personal tools